Synthesis of oligonucleotides or phosphorothioate oligonucleotide with a capping agent of N-methylimidazole free of 1,3,5-trimethylhexahydro-1,3,5-triazine
View Patent ↗According to the present invention, there is provided a process for making an oligonucleotide or a phosphorothioate oligonucleotide. The process has the following steps: (a) providing an amount of a blocked nucleotide; (b) deblocking the blocked nucleotide to form an unblocked nucleotide; (c) activating the deblocked nucleotide; (d) coupling the deblocked nucleotide with a phosphoramidite to form a phosphite oligomer; (e) capping any uncoupled deblocked nucleotide via reaction with an amount of acetic anhydride and an amount of N-methylimidazole that is substantially free of 1,3,5-trimethylhexahydro-1,3,5-triazine; (f) oxidizing the phosphite oligomer to form the oligonucleotide or sulfurizing the phosphite oligomer to form a phosphorothioate oligonucleotide; and (g) optionally repeating steps (b) through (f). There is also a process for capping a nucleotide.
1. An improved process of making oligonucleotides that includes steps of deblocking blocked nucleotide having a dimethoxytrityl group blocking a 5′-hydroxyl group, activating the deblocked nucleotide, reacting deblocked nucleotide with a phosphoramidite to form phosphite oligomer, and capping unreacted deblocked nucleotide, wherein the improvement comprises capping unreacted deblocked nucleotide by reacting the unreacted deblocked nucleotide with an amount of acetic anhydride and an amount of N-methylimidazole that is substantially free of 1,3,5-trimethylhexahydro-1,3,5-triazine.
2. The process of claim 1 , wherein the wherein the N-methylimidazole has a content of about 10 ppm or less 1,3,5-trimethylhexahydro-1,3,5-triazine based on the weight of the N-methylimidazole.
3. The process of claim 1 , further comprising wherein the process steps are repeated until the desired oligonucleotide length is achieved.